SIGI
INDV icon

Susquehanna International Group (Ireland)’s Indivior Pharmaceuticals INDV Stock Holding History

Susquehanna International Group (Ireland)’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.24M Sell
127,341
-72,659
-36% -$851K 0.26% 39
2024
Q2 		$3.22M Buy
+200,000
New +$3.61M 0.81% 18

Other funds holding INDV

TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
LIP
Liontrust Investment Partners London, United Kingdom $6.8B AUM 23.31% 1-Year Est. Return

Susquehanna International Group (Ireland)'s INDV Position: Q3 2024 in Review

Susquehanna International Group (Ireland) reduced its Indivior Pharmaceuticals (INDV) stake by 36% in Q3 2024, selling an estimated $851K and leaving 127,341 shares worth $1.24M. The position accounts for 0.26% of the portfolio, ranked #39.

Susquehanna International Group (Ireland) first reported a position in INDV in Q2 2024 and has held it in 2 quarters since. The position peaked at $3.22M in Q2 2024. 103 funds tracked by Wall St. Rank hold INDV as of Q3 2024.

  • Susquehanna International Group (Ireland) held 127,341 shares of Indivior Pharmaceuticals worth $1.24M as of Q3 2024.
  • Susquehanna International Group (Ireland) sold 72,659 Indivior Pharmaceuticals shares in Q3 2024, an estimated $851K.
  • Indivior Pharmaceuticals made up 0.26% of Susquehanna International Group (Ireland)'s portfolio in Q3 2024, its #39 holding.
  • Susquehanna International Group (Ireland) first reported a position in Indivior Pharmaceuticals in Q2 2024 and has held it in 2 quarters since.
  • Susquehanna International Group (Ireland)'s Indivior Pharmaceuticals position peaked at $3.22M in Q2 2024.
  • 103 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q3 2024.

Based on Susquehanna International Group (Ireland)'s 13F filing for Q3 2024, filed 14 Nov 2024.